Equus asinus breed Dezhou chromosome 19, ASM1607732v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
Donkey genomes provide new insights into domestication and selection for coat color
REFSEQ INFORMATION: The reference sequence is identical to\nCM027708.2.\nAssembly name: ASM1607732v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Dairy Cattle Research Center,\nShandong Academy of Agricultural Sciences on 2021/10/14. The\noriginal whole-genome shotgun project has the accession\nJADWZW000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Dairy Cattle Research Center, Shandong\n Academy of Agricultural Sciences\nAssembly Method :: SOAPdenovo v. 2.04.4; DBG2OLC v. 1;\n 3D-DNA v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 211.0x\nSequencing Technology :: Illumina HiSeq; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Equus asinus Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
adhesion G protein-coupled receptor E2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: contactin-associated protein-like 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
receptor transporter protein 5 (putative)
LOW QUALITY PROTEIN: receptor-transporting protein 5
programmed cell death 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
programmed cell death 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
programmed cell death 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
programmed cell death protein 1 isoform X3
programmed cell death protein 1 isoform X1
programmed cell death protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
D-2-hydroxyglutarate dehydrogenase, transcript variant X2
D-2-hydroxyglutarate dehydrogenase, transcript variant X1
D-2-hydroxyglutarate dehydrogenase, transcript variant X3
D-2-hydroxyglutarate dehydrogenase, mitochondrial isoform X2
D-2-hydroxyglutarate dehydrogenase, mitochondrial isoform X1
inhibitor of growth family member 5, transcript variant X1
inhibitor of growth family member 5, transcript variant X2
inhibitor of growth family member 5, transcript variant X3
inhibitor of growth family member 5, transcript variant X4
inhibitor of growth protein 5 isoform X1
inhibitor of growth protein 5 isoform X2
deoxythymidylate kinase, transcript variant X1
deoxythymidylate kinase, transcript variant X2
THAP domain containing 4, transcript variant X1
peroxynitrite isomerase THAP4 isoform X1
THAP domain containing 4, transcript variant X2
peroxynitrite isomerase THAP4 isoform X2
THAP domain containing 4, transcript variant X3
peroxynitrite isomerase THAP4 isoform X3
BCL2 family apoptosis regulator BOK, transcript variant X2
BCL2 family apoptosis regulator BOK, transcript variant X1
serine/threonine kinase 25, transcript variant X1
serine/threonine kinase 25, transcript variant X4
serine/threonine kinase 25, transcript variant X5
serine/threonine kinase 25, transcript variant X3
serine/threonine kinase 25, transcript variant X2
serine/threonine-protein kinase 25 isoform X1
serine/threonine-protein kinase 25 isoform X2
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X6
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X5
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X4
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X2
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X3
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X1
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X6
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X5
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X4
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X2
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X3
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X1
high density lipoprotein binding protein, transcript variant X3
high density lipoprotein binding protein, transcript variant X2
high density lipoprotein binding protein, transcript variant X1
protein phosphatase 1 regulatory subunit 7, transcript variant X2
protein phosphatase 1 regulatory subunit 7, transcript variant X3
protein phosphatase 1 regulatory subunit 7, transcript variant X1
protein phosphatase 1 regulatory subunit 7, transcript variant X4
protein phosphatase 1 regulatory subunit 7, transcript variant X5
protein phosphatase 1 regulatory subunit 7 isoform X1
protein phosphatase 1 regulatory subunit 7 isoform X2
protein phosphatase 1 regulatory subunit 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7 isoform X3
protein phosphatase 1 regulatory subunit 7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7 isoform X5
protein phosphatase 1 regulatory subunit 7, transcript variant X9
protein phosphatase 1 regulatory subunit 7, transcript variant X7
protein phosphatase 1 regulatory subunit 7 isoform X4
protein phosphatase 1 regulatory subunit 7 isoform X6
PAS domain containing serine/threonine kinase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PAS domain-containing serine/threonine-protein kinase
mitochondrial transcription termination factor 4, transcript variant X1
transcription termination factor 4, mitochondrial isoform X1
mitochondrial transcription termination factor 4, transcript variant X2
mitochondrial transcription termination factor 4, transcript variant X3
mitochondrial transcription termination factor 4, transcript variant X4
transcription termination factor 4, mitochondrial isoform X2
transcription termination factor 4, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
sushi, nidogen and EGF-like domain-containing protein 1
ciliary rootlet coiled-coil, rootletin family member 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ciliary rootlet coiled-coil protein 2
LOW QUALITY PROTEIN: protein mab-21-like 4
alanine--glyoxylate and serine--pyruvate aminotransferase
kinesin family member 1A, transcript variant X2
kinesin family member 1A, transcript variant X1
kinesin family member 1A, transcript variant X5
kinesin family member 1A, transcript variant X6
kinesin family member 1A, transcript variant X9
kinesin family member 1A, transcript variant X3
kinesin family member 1A, transcript variant X8
kinesin family member 1A, transcript variant X10
kinesin family member 1A, transcript variant X4
kinesin family member 1A, transcript variant X30
kinesin family member 1A, transcript variant X17
kinesin family member 1A, transcript variant X18
kinesin family member 1A, transcript variant X19
kinesin family member 1A, transcript variant X20
kinesin family member 1A, transcript variant X11
kinesin family member 1A, transcript variant X13
kinesin family member 1A, transcript variant X23
kinesin family member 1A, transcript variant X24
kinesin family member 1A, transcript variant X26
kinesin family member 1A, transcript variant X7
kinesin family member 1A, transcript variant X21
kinesin family member 1A, transcript variant X22
kinesin family member 1A, transcript variant X12
kinesin family member 1A, transcript variant X14
kinesin family member 1A, transcript variant X16
kinesin family member 1A, transcript variant X15
kinesin family member 1A, transcript variant X25
kinesin family member 1A, transcript variant X27
kinesin family member 1A, transcript variant X28
kinesin family member 1A, transcript variant X29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123278559, transcript variant X2
uncharacterized LOC123278559, transcript variant X1
G protein-coupled receptor 35, transcript variant X3
G protein-coupled receptor 35, transcript variant X2
G protein-coupled receptor 35, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
LOW QUALITY PROTEIN: aminopeptidase RNPEPL1
ankyrin repeat and MYND domain containing 1, transcript variant X4
ankyrin repeat and MYND domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and MYND domain containing 1, transcript variant X1
ankyrin repeat and MYND domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat and MYND domain-containing protein 1 isoform X1
ankyrin repeat and MYND domain-containing protein 1 isoform X4
ankyrin repeat and MYND domain-containing protein 1 isoform X2
ankyrin repeat and MYND domain-containing protein 1 isoform X3
uncharacterized LOC123278530, transcript variant X1
uncharacterized LOC123278530, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
S-adenosylmethionine decarboxylase proenzyme-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase subunit A10, transcript variant X1
NADH:ubiquinone oxidoreductase subunit A10, transcript variant X3
NADH:ubiquinone oxidoreductase subunit A10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial isoform X2
uncharacterized LOC106832224, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106832224, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC106832205, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC106832205, transcript variant X2
uncharacterized LOC123278466, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123278466, transcript variant X3
uncharacterized LOC123278466, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
LOW QUALITY PROTEIN: histone deacetylase 4
twist family bHLH transcription factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 1, transcript variant X3
ankyrin repeat and SOCS box containing 1, transcript variant X1
ankyrin repeat and SOCS box containing 1, transcript variant X2
ankyrin repeat and SOCS box protein 1 isoform X3
ankyrin repeat and SOCS box protein 1 isoform X1
ankyrin repeat and SOCS box protein 1 isoform X2
TRAF3 interacting protein 1, transcript variant X11
TRAF3 interacting protein 1, transcript variant X2
TRAF3 interacting protein 1, transcript variant X4
TRAF3 interacting protein 1, transcript variant X1
TRAF3 interacting protein 1, transcript variant X9
TRAF3 interacting protein 1, transcript variant X7
TRAF3 interacting protein 1, transcript variant X5
TRAF3 interacting protein 1, transcript variant X3
TRAF3 interacting protein 1, transcript variant X8
TRAF3 interacting protein 1, transcript variant X6
TRAF3 interacting protein 1, transcript variant X10
LOW QUALITY PROTEIN: period circadian protein homolog 2
hes family bHLH transcription factor 6, transcript variant X1
hes family bHLH transcription factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments
ILK associated serine/threonine phosphatase, transcript variant X1
integrin-linked kinase-associated serine/threonine phosphatase 2C isoform X1
ILK associated serine/threonine phosphatase, transcript variant X2
integrin-linked kinase-associated serine/threonine phosphatase 2C isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
selenocysteine lyase, transcript variant X4
selenocysteine lyase, transcript variant X5
selenocysteine lyase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
selenocysteine lyase, transcript variant X10
selenocysteine lyase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
selenocysteine lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
selenocysteine lyase, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
selenocysteine lyase, transcript variant X12
selenocysteine lyase, transcript variant X6
selenocysteine lyase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
selenocysteine lyase, transcript variant X8
selenocysteine lyase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 F (putative), transcript variant X2
ubiquitin conjugating enzyme E2 F (putative), transcript variant X1
NEDD8-conjugating enzyme UBE2F isoform X2
NEDD8-conjugating enzyme UBE2F isoform X1
RNA binding motif protein 44, transcript variant X1
RNA binding motif protein 44, transcript variant X2
LOW QUALITY PROTEIN: leucine-rich repeat flightless-interacting protein 1
RAB17, member RAS oncogene family, transcript variant X3
RAB17, member RAS oncogene family, transcript variant X4
RAB17, member RAS oncogene family, transcript variant X1
RAB17, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123278498, transcript variant X2
uncharacterized LOC123278498, transcript variant X3
uncharacterized LOC123278498, transcript variant X1
collagen type VI alpha 3 chain, transcript variant X1
collagen type VI alpha 3 chain, transcript variant X3
collagen type VI alpha 3 chain, transcript variant X4
collagen type VI alpha 3 chain, transcript variant X5
collagen type VI alpha 3 chain, transcript variant X6
collagen type VI alpha 3 chain, transcript variant X7
collagen type VI alpha 3 chain, transcript variant X2
COP9 signalosome subunit 8, transcript variant X2
COP9 signalosome subunit 8, transcript variant X3
COP9 signalosome subunit 8, transcript variant X4
COP9 signalosome subunit 8, transcript variant X1
COP9 signalosome subunit 8, transcript variant X5
COP9 signalosome complex subunit 8 isoform X2
COP9 signalosome complex subunit 8 isoform X1
COP9 signalosome complex subunit 8 isoform X3
uncharacterized LOC123278422, transcript variant X2
uncharacterized LOC123278422, transcript variant X1
uncharacterized LOC123278511, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123278511, transcript variant X6
uncharacterized LOC123278511, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123278511, transcript variant X1
uncharacterized LOC123278511, transcript variant X7
uncharacterized LOC123278511, transcript variant X3
uncharacterized LOC123278511, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123278511, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123278478, transcript variant X2
uncharacterized LOC123278478, transcript variant X3
uncharacterized LOC123278478, transcript variant X1
uncharacterized LOC123278488, transcript variant X2
uncharacterized LOC123278488, transcript variant X1
atypical chemokine receptor 3, transcript variant X1
atypical chemokine receptor 3, transcript variant X2
ankyrin repeat and SOCS box containing 18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
gastrulation brain homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gastrulation brain homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X6
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X7
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X8
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X9
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X4
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X5
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, transcript variant X3
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X9
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X8
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X7
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X6
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X2
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X4
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X5
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X3
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00402
uncharacterized LOC123278553, transcript variant X2
uncharacterized LOC123278553, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
SH3 domain binding protein 4, transcript variant X3
SH3 domain binding protein 4, transcript variant X1
SH3 domain binding protein 4, transcript variant X2
SH3 domain binding protein 4, transcript variant X4
uncharacterized LOC123278475, transcript variant X2
uncharacterized LOC123278475, transcript variant X1
uncharacterized LOC106844764, transcript variant X4
uncharacterized LOC106844764, transcript variant X1
uncharacterized LOC106844764, transcript variant X2
uncharacterized LOC106844764, transcript variant X3
uncharacterized LOC123278540, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123278540, transcript variant X2
uncharacterized LOC123278540, transcript variant X1
uncharacterized LOC123278540, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transient receptor potential cation channel subfamily M member 8
maestro heat like repeat family member 2A, transcript variant X2
maestro heat like repeat family member 2A, transcript variant X3
maestro heat like repeat family member 2A, transcript variant X1
maestro heat like repeat family member 2A, transcript variant X4
maestro heat-like repeat-containing protein family member 2A isoform X3
maestro heat-like repeat-containing protein family member 2A isoform X2
maestro heat-like repeat-containing protein family member 2A isoform X1
maestro heat-like repeat-containing protein family member 2A isoform X4
UDP-glucuronosyltransferase 1-6-like, transcript variant X6
UDP-glucuronosyltransferase 1-6-like, transcript variant X4
UDP-glucuronosyltransferase 1-6-like, transcript variant X5
UDP-glucuronosyltransferase 1-6-like, transcript variant X3
UDP-glucuronosyltransferase 1-6-like, transcript variant X2
UDP-glucuronosyltransferase 1-6-like, transcript variant X1
UDP-glucuronosyltransferase 1A10-like isoform X6
UDP-glucuronosyltransferase 1-6-like isoform X4
UDP-glucuronosyltransferase 1-6-like isoform X5
UDP-glucuronosyltransferase 1-6-like isoform X3
UDP-glucuronosyltransferase 1A3-like isoform X2
UDP-glucuronosyltransferase 1A1-like isoform X1
DnaJ heat shock protein family (Hsp40) member B3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 40, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin specific peptidase 40, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: UDP-glucuronosyltransferase 1A10-like
ubiquitin specific peptidase 40, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ubiquitin specific peptidase 40, transcript variant X11
ubiquitin specific peptidase 40, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ubiquitin specific peptidase 40, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
ubiquitin specific peptidase 40, transcript variant X7
ubiquitin specific peptidase 40, transcript variant X6
ubiquitin specific peptidase 40, transcript variant X2
ubiquitin specific peptidase 40, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 40 isoform X1
ubiquitin carboxyl-terminal hydrolase 40 isoform X2
ubiquitin carboxyl-terminal hydrolase 40 isoform X5
ubiquitin carboxyl-terminal hydrolase 40 isoform X4
ubiquitin carboxyl-terminal hydrolase 40 isoform X6
ubiquitin carboxyl-terminal hydrolase 40 isoform X8
ubiquitin carboxyl-terminal hydrolase 40 isoform X9
ubiquitin specific peptidase 40, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 40 isoform X3
ubiquitin specific peptidase 40, transcript variant X10
ubiquitin specific peptidase 40, transcript variant X9
ubiquitin specific peptidase 40, transcript variant X14
ubiquitin specific peptidase 40, transcript variant X15
ubiquitin specific peptidase 40, transcript variant X16
ubiquitin carboxyl-terminal hydrolase 40 isoform X7
ubiquitin carboxyl-terminal hydrolase 40 isoform X10
ubiquitin carboxyl-terminal hydrolase 40 isoform X11
ubiquitin carboxyl-terminal hydrolase 40 isoform X12
ubiquitin specific peptidase 40, transcript variant X17
ubiquitin carboxyl-terminal hydrolase 40 isoform X13
ubiquitin specific peptidase 40, transcript variant X19
ubiquitin specific peptidase 40, transcript variant X18
ubiquitin carboxyl-terminal hydrolase 40 isoform X14
ubiquitin carboxyl-terminal hydrolase 40 isoform X15
ubiquitin specific peptidase 40, transcript variant X20
ubiquitin specific peptidase 40, transcript variant X21
ubiquitin carboxyl-terminal hydrolase 40 isoform X16
ubiquitin carboxyl-terminal hydrolase 40 isoform X17
diacylglycerol kinase delta, transcript variant X3
diacylglycerol kinase delta, transcript variant X2
diacylglycerol kinase delta, transcript variant X1
diacylglycerol kinase delta, transcript variant X4
diacylglycerol kinase delta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
S-antigen visual arrestin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
S-antigen visual arrestin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
autophagy related 16 like 1, transcript variant X1
autophagy related 16 like 1, transcript variant X2
autophagy related 16 like 1, transcript variant X3
autophagy-related protein 16-1 isoform X3
autophagy-related protein 16-1 isoform X2
autophagy-related protein 16-1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00478
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1
neuronal guanine nucleotide exchange factor, transcript variant X1
neuronal guanine nucleotide exchange factor, transcript variant X2
secondary ossification center associated regulator of chondrocyte maturation, transcript variant X1
secondary ossification center associated regulator of chondrocyte maturation, transcript variant X2
GRB10 interacting GYF protein 2, transcript variant X8
GRB10 interacting GYF protein 2, transcript variant X7
GRB10 interacting GYF protein 2, transcript variant X6
GRB10 interacting GYF protein 2, transcript variant X1
GRB10 interacting GYF protein 2, transcript variant X4
GRB10 interacting GYF protein 2, transcript variant X2
GRB10 interacting GYF protein 2, transcript variant X3
GRB10 interacting GYF protein 2, transcript variant X5
GRB10 interacting GYF protein 2, transcript variant X9
GRB10 interacting GYF protein 2, transcript variant X10
GRB10-interacting GYF protein 2 isoform X4
GRB10-interacting GYF protein 2 isoform X3
GRB10-interacting GYF protein 2 isoform X2
GRB10-interacting GYF protein 2 isoform X1
GRB10-interacting GYF protein 2 isoform X6
GRB10-interacting GYF protein 2 isoform X5
potassium inwardly rectifying channel subfamily J member 13, transcript variant X1
potassium inwardly rectifying channel subfamily J member 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inward rectifier potassium channel 13 isoform X1
inward rectifier potassium channel 13 isoform X2
EF-hand domain family member D1, transcript variant X1
EF-hand domain family member D1, transcript variant X2
EF-hand domain-containing protein D1 isoform X1
EF-hand domain-containing protein D1 isoform X2
eukaryotic translation initiation factor 4E family member 2, transcript variant X3
eukaryotic translation initiation factor 4E family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
eukaryotic translation initiation factor 4E type 2 isoform X3
eukaryotic translation initiation factor 4E type 2 isoform X2
eukaryotic translation initiation factor 4E family member 2, transcript variant X1
eukaryotic translation initiation factor 4E type 2 isoform X1
cholinergic receptor nicotinic gamma subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic delta subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cholinergic receptor nicotinic delta subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine protease 56, transcript variant X2
serine protease 56, transcript variant X1
endothelin converting enzyme like 1, transcript variant X2
endothelin converting enzyme like 1, transcript variant X1
endothelin-converting enzyme-like 1 isoform X2
endothelin-converting enzyme-like 1 isoform X1
intestinal-type alkaline phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 31 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: intestinal-type alkaline phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
DIS3 like 3'-5' exoribonuclease 2, transcript variant X2
DIS3 like 3'-5' exoribonuclease 2, transcript variant X3
DIS3 like 3'-5' exoribonuclease 2, transcript variant X4
DIS3 like 3'-5' exoribonuclease 2, transcript variant X1
DIS3 like 3'-5' exoribonuclease 2, transcript variant X5
DIS3 like 3'-5' exoribonuclease 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
COP9 signalosome subunit 7B, transcript variant X2
COP9 signalosome subunit 7B, transcript variant X3
COP9 signalosome subunit 7B, transcript variant X1
COP9 signalosome complex subunit 7b isoform X2
COP9 signalosome complex subunit 7b isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta
translation initiation factor IF-2-like, transcript variant X8
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X5
translation initiation factor IF-2-like, transcript variant X4
translation initiation factor IF-2-like, transcript variant X7
translation initiation factor IF-2-like, transcript variant X6
translation initiation factor IF-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X3
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X2
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X3
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X4
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X5
general transcription factor II-I repeat domain-containing protein 2-like, transcript variant X6
general transcription factor II-I repeat domain-containing protein 2-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00158
COORDINATES: nucleotide motif:Rfam:12.0:RF00217
COORDINATES: nucleotide motif:Rfam:12.0:RF00072
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
armadillo repeat containing 9, transcript variant X1
armadillo repeat containing 9, transcript variant X6
armadillo repeat containing 9, transcript variant X4
armadillo repeat containing 9, transcript variant X10
armadillo repeat containing 9, transcript variant X5
armadillo repeat containing 9, transcript variant X2
armadillo repeat containing 9, transcript variant X3
armadillo repeat containing 9, transcript variant X12
lisH domain-containing protein ARMC9 isoform X4
lisH domain-containing protein ARMC9 isoform X3
lisH domain-containing protein ARMC9 isoform X2
lisH domain-containing protein ARMC9 isoform X10
lisH domain-containing protein ARMC9 isoform X1
lisH domain-containing protein ARMC9 isoform X8
armadillo repeat containing 9, transcript variant X8
lisH domain-containing protein ARMC9 isoform X6
armadillo repeat containing 9, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
lisH domain-containing protein ARMC9 isoform X7
armadillo repeat containing 9, transcript variant X7
armadillo repeat containing 9, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
lisH domain-containing protein ARMC9 isoform X9
lisH domain-containing protein ARMC9 isoform X5
armadillo repeat containing 9, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
proteasome 26S subunit, non-ATPase 1, transcript variant X2
proteasome 26S subunit, non-ATPase 1, transcript variant X1
26S proteasome non-ATPase regulatory subunit 1 isoform X1
26S proteasome non-ATPase regulatory subunit 1 isoform X2
uncharacterized LOC123278432, transcript variant X2
uncharacterized LOC123278432, transcript variant X1
5-hydroxytryptamine receptor 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
5-hydroxytryptamine receptor 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
5-hydroxytryptamine receptor 2B isoform X1
5-hydroxytryptamine receptor 2B isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein C2orf72 homolog
spermatogenesis associated 3, transcript variant X1
spermatogenesis associated 3, transcript variant X2
spermatogenesis-associated protein 3 isoform X1
spermatogenesis-associated protein 3 isoform X2
G protein-coupled receptor 55, transcript variant X2
G-protein coupled receptor 55 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
G protein-coupled receptor 55, transcript variant X1
G-protein coupled receptor 55 isoform X1
calcium binding protein 39, transcript variant X2
calcium binding protein 39, transcript variant X1
SP100 nuclear antigen, transcript variant X6
SP100 nuclear antigen, transcript variant X2
SP100 nuclear antigen, transcript variant X4
SP100 nuclear antigen, transcript variant X9
SP100 nuclear antigen, transcript variant X7
SP100 nuclear antigen, transcript variant X10
SP100 nuclear antigen, transcript variant X8
SP100 nuclear antigen, transcript variant X5
SP100 nuclear antigen, transcript variant X3
SP100 nuclear antigen, transcript variant X1
SP140 nuclear body protein like, transcript variant X1
SP140 nuclear body protein like, transcript variant X2
nuclear body protein SP140-like protein isoform X2
nuclear body protein SP140-like protein isoform X1
nuclear body protein SP140-like, transcript variant X14
nuclear body protein SP140-like, transcript variant X5
nuclear body protein SP140-like, transcript variant X6
nuclear body protein SP140-like, transcript variant X2
nuclear body protein SP140-like, transcript variant X16
nuclear body protein SP140-like, transcript variant X13
nuclear body protein SP140-like, transcript variant X4
nuclear body protein SP140-like, transcript variant X15
nuclear body protein SP140-like, transcript variant X10
nuclear body protein SP140-like, transcript variant X12
nuclear body protein SP140-like, transcript variant X11
nuclear body protein SP140-like, transcript variant X9
nuclear body protein SP140-like, transcript variant X8
nuclear body protein SP140-like, transcript variant X3
nuclear body protein SP140-like, transcript variant X1
nuclear body protein SP140-like, transcript variant X7
nuclear body protein SP140-like isoform X12
nuclear body protein SP140-like isoform X4
nuclear body protein SP140-like isoform X14
nuclear body protein SP140-like isoform X11
nuclear body protein SP140-like isoform X3
nuclear body protein SP140-like isoform X13
nuclear body protein SP140-like isoform X8
nuclear body protein SP140-like isoform X10
nuclear body protein SP140-like isoform X9
nuclear body protein SP140-like isoform X7
nuclear body protein SP140-like isoform X6
nuclear body protein SP140-like isoform X2
nuclear body protein SP140-like isoform X1
nuclear body protein SP140-like isoform X5
LOW QUALITY PROTEIN: sp110 nuclear body protein
probable G-protein coupled receptor 148, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable G-protein coupled receptor 148, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
probable G-protein coupled receptor 148 isoform X1
probable G-protein coupled receptor 148 isoform X2
thyroid hormone receptor interactor 12, transcript variant X5
thyroid hormone receptor interactor 12, transcript variant X3
thyroid hormone receptor interactor 12, transcript variant X1
thyroid hormone receptor interactor 12, transcript variant X7
thyroid hormone receptor interactor 12, transcript variant X10
thyroid hormone receptor interactor 12, transcript variant X8
thyroid hormone receptor interactor 12, transcript variant X11
thyroid hormone receptor interactor 12, transcript variant X9
thyroid hormone receptor interactor 12, transcript variant X17
thyroid hormone receptor interactor 12, transcript variant X12
thyroid hormone receptor interactor 12, transcript variant X13
thyroid hormone receptor interactor 12, transcript variant X18
thyroid hormone receptor interactor 12, transcript variant X14
thyroid hormone receptor interactor 12, transcript variant X15
thyroid hormone receptor interactor 12, transcript variant X16
thyroid hormone receptor interactor 12, transcript variant X19
thyroid hormone receptor interactor 12, transcript variant X20
thyroid hormone receptor interactor 12, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
thyroid hormone receptor interactor 12, transcript variant X21
thyroid hormone receptor interactor 12, transcript variant X2
thyroid hormone receptor interactor 12, transcript variant X6
thyroid hormone receptor interactor 12, transcript variant X4
E3 ubiquitin-protein ligase TRIP12 isoform X1
E3 ubiquitin-protein ligase TRIP12 isoform X3
E3 ubiquitin-protein ligase TRIP12 isoform X6
E3 ubiquitin-protein ligase TRIP12 isoform X2
E3 ubiquitin-protein ligase TRIP12 isoform X4
E3 ubiquitin-protein ligase TRIP12 isoform X7
E3 ubiquitin-protein ligase TRIP12 isoform X5
E3 ubiquitin-protein ligase TRIP12 isoform X13
E3 ubiquitin-protein ligase TRIP12 isoform X8
E3 ubiquitin-protein ligase TRIP12 isoform X9
E3 ubiquitin-protein ligase TRIP12 isoform X14
E3 ubiquitin-protein ligase TRIP12 isoform X10
E3 ubiquitin-protein ligase TRIP12 isoform X11
E3 ubiquitin-protein ligase TRIP12 isoform X12
E3 ubiquitin-protein ligase TRIP12 isoform X15
E3 ubiquitin-protein ligase TRIP12 isoform X16
E3 ubiquitin-protein ligase TRIP12 isoform X17
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: delta and Notch-like epidermal growth factor-related receptor
phosphotyrosine interaction domain containing 1, transcript variant X3
phosphotyrosine interaction domain containing 1, transcript variant X1
phosphotyrosine interaction domain containing 1, transcript variant X2
PTB-containing, cubilin and LRP1-interacting protein isoform X1
PTB-containing, cubilin and LRP1-interacting protein isoform X2
phosphotyrosine interaction domain containing 1, transcript variant X5
PTB-containing, cubilin and LRP1-interacting protein isoform X4
phosphotyrosine interaction domain containing 1, transcript variant X4
PTB-containing, cubilin and LRP1-interacting protein isoform X3
uncharacterized LOC123278480, transcript variant X1
uncharacterized LOC123278480, transcript variant X2
uncharacterized LOC123278479, transcript variant X4
uncharacterized LOC123278479, transcript variant X6
uncharacterized LOC123278479, transcript variant X1
uncharacterized LOC123278479, transcript variant X2
uncharacterized LOC123278479, transcript variant X5
uncharacterized LOC123278479, transcript variant X3
uncharacterized LOC123278481, transcript variant X2
uncharacterized LOC123278481, transcript variant X1
SPHK1 interactor, AKAP domain containing
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: A-kinase anchor protein SPHKAP
dynein assembly factor with WD repeats 1, transcript variant X6
dynein assembly factor with WDR repeat domains 1 isoform X6
dynein assembly factor with WD repeats 1, transcript variant X3
dynein assembly factor with WD repeats 1, transcript variant X1
dynein assembly factor with WD repeats 1, transcript variant X2
dynein assembly factor with WD repeats 1, transcript variant X4
dynein assembly factor with WD repeats 1, transcript variant X5
dynein assembly factor with WDR repeat domains 1 isoform X5
dynein assembly factor with WDR repeat domains 1 isoform X4
dynein assembly factor with WDR repeat domains 1 isoform X3
dynein assembly factor with WDR repeat domains 1 isoform X2
dynein assembly factor with WDR repeat domains 1 isoform X1
dynein assembly factor with WD repeats 1, transcript variant X7
dynein assembly factor with WDR repeat domains 1 isoform X7
C-C motif chemokine ligand 20, transcript variant X1
C-C motif chemokine ligand 20, transcript variant X2
solute carrier family 19 member 3, transcript variant X2
solute carrier family 19 member 3, transcript variant X3
solute carrier family 19 member 3, transcript variant X1
small cysteine and glycine repeat-containing protein 7-like
SKI family transcriptional corepressor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with FG repeats 1, transcript variant X1
ArfGAP with FG repeats 1, transcript variant X3
ArfGAP with FG repeats 1, transcript variant X6
ArfGAP with FG repeats 1, transcript variant X5
ArfGAP with FG repeats 1, transcript variant X7
ArfGAP with FG repeats 1, transcript variant X2
ArfGAP with FG repeats 1, transcript variant X4
arf-GAP domain and FG repeat-containing protein 1 isoform X6
arf-GAP domain and FG repeat-containing protein 1 isoform X5
arf-GAP domain and FG repeat-containing protein 1 isoform X3
arf-GAP domain and FG repeat-containing protein 1 isoform X1
arf-GAP domain and FG repeat-containing protein 1 isoform X4
arf-GAP domain and FG repeat-containing protein 1 isoform X2
arf-GAP domain and FG repeat-containing protein 1 isoform X7
mitochondrial fission factor, transcript variant X9
mitochondrial fission factor, transcript variant X4
mitochondrial fission factor, transcript variant X1
mitochondrial fission factor, transcript variant X7
mitochondrial fission factor, transcript variant X3
mitochondrial fission factor, transcript variant X2
mitochondrial fission factor, transcript variant X5
mitochondrial fission factor, transcript variant X8
mitochondrial fission factor, transcript variant X6
mitochondrial fission factor, transcript variant X18
mitochondrial fission factor, transcript variant X16
mitochondrial fission factor, transcript variant X10
mitochondrial fission factor, transcript variant X19
mitochondrial fission factor, transcript variant X12
mitochondrial fission factor, transcript variant X24
mitochondrial fission factor, transcript variant X14
mitochondrial fission factor, transcript variant X15
mitochondrial fission factor, transcript variant X25
mitochondrial fission factor, transcript variant X11
mitochondrial fission factor, transcript variant X13
mitochondrial fission factor, transcript variant X21
mitochondrial fission factor, transcript variant X17
mitochondrial fission factor, transcript variant X22
mitochondrial fission factor, transcript variant X23
mitochondrial fission factor, transcript variant X20
mitochondrial fission factor isoform X13
mitochondrial fission factor isoform X11
mitochondrial fission factor isoform X14
mitochondrial fission factor isoform X12
mitochondrial fission factor isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: collagen alpha-3(IV) chain
collagen type IV alpha 4 chain, transcript variant X7
collagen type IV alpha 4 chain, transcript variant X6
collagen type IV alpha 4 chain, transcript variant X3
collagen type IV alpha 4 chain, transcript variant X1
collagen type IV alpha 4 chain, transcript variant X2
collagen type IV alpha 4 chain, transcript variant X4
collagen type IV alpha 4 chain, transcript variant X5
collagen type IV alpha 4 chain, transcript variant X8
collagen type IV alpha 4 chain, transcript variant X9
rhomboid domain containing 1, transcript variant X2
rhomboid domain containing 1, transcript variant X4
rhomboid domain containing 1, transcript variant X1
rhomboid domain containing 1, transcript variant X3
uncharacterized LOC106827895, transcript variant X1
uncharacterized LOC106827895, transcript variant X2
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 isoform X1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 isoform X2
dedicator of cytokinesis 10, transcript variant X3
dedicator of cytokinesis protein 10 isoform X3
dedicator of cytokinesis 10, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dedicator of cytokinesis 10, transcript variant X7
dedicator of cytokinesis 10, transcript variant X2
dedicator of cytokinesis 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 ESTs, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dedicator of cytokinesis 10, transcript variant X1
dedicator of cytokinesis 10, transcript variant X5
dedicator of cytokinesis protein 10 isoform X10
dedicator of cytokinesis protein 10 isoform X5
dedicator of cytokinesis protein 10 isoform X1
dedicator of cytokinesis protein 10 isoform X7
dedicator of cytokinesis protein 10 isoform X2
dedicator of cytokinesis protein 10 isoform X9
dedicator of cytokinesis 10, transcript variant X4
dedicator of cytokinesis 10, transcript variant X8
dedicator of cytokinesis 10, transcript variant X6
dedicator of cytokinesis 10, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 3 ESTs, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dedicator of cytokinesis protein 10 isoform X11
dedicator of cytokinesis protein 10 isoform X8
dedicator of cytokinesis protein 10 isoform X4
dedicator of cytokinesis protein 10 isoform X6
putative coiled-coil domain-containing protein 195
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 19% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 124 member B
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
39S ribosomal protein L44, mitochondrial
WD repeat and FYVE domain containing 1, transcript variant X1
WD repeat and FYVE domain-containing protein 1 isoform X1
WD repeat and FYVE domain containing 1, transcript variant X2
WD repeat and FYVE domain-containing protein 1 isoform X2
adaptor related protein complex 1 subunit sigma 3
potassium voltage-gated channel subfamily E regulatory subunit 4
potassium voltage-gated channel subfamily E member 4
acyl-CoA synthetase long chain family member 3
LOW QUALITY PROTEIN: long-chain-fatty-acid--CoA ligase 3
uncharacterized LOC123278558, transcript variant X1
uncharacterized LOC123278558, transcript variant X2
phenylalanyl-tRNA synthetase subunit beta, transcript variant X3
phenylalanyl-tRNA synthetase subunit beta, transcript variant X2
phenylalanyl-tRNA synthetase subunit beta, transcript variant X1
phenylalanine--tRNA ligase beta subunit isoform X1
phenylalanine--tRNA ligase beta subunit isoform X3
phenylalanine--tRNA ligase beta subunit isoform X2
uncharacterized LOC123278418, transcript variant X2
uncharacterized LOC123278418, transcript variant X1
sphingosine-1-phosphate phosphatase 2, transcript variant X1
sphingosine-1-phosphate phosphatase 2, transcript variant X2
sphingosine-1-phosphate phosphatase 2 isoform X1
sphingosine-1-phosphate phosphatase 2 isoform X2
uncharacterized LOC123278461, transcript variant X2
uncharacterized LOC123278461, transcript variant X3
uncharacterized LOC123278461, transcript variant X1
uncharacterized LOC123278524, transcript variant X2
uncharacterized LOC123278524, transcript variant X1
uncharacterized LOC106832483, transcript variant X2
uncharacterized LOC106832483, transcript variant X1
solute carrier family 4 member 3, transcript variant X2
solute carrier family 4 member 3, transcript variant X1
serine/threonine kinase 11 interacting protein, transcript variant X1
serine/threonine kinase 11 interacting protein, transcript variant X2
serine/threonine-protein kinase 11-interacting protein isoform X1
serine/threonine kinase 11 interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
serine/threonine-protein kinase 11-interacting protein isoform X2
serine/threonine kinase 11 interacting protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein kinase 11-interacting protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
obscurin like cytoskeletal adaptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
obscurin like cytoskeletal adaptor 1, transcript variant X1
obscurin like cytoskeletal adaptor 1, transcript variant X4
obscurin like cytoskeletal adaptor 1, transcript variant X5
obscurin like cytoskeletal adaptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
obscurin like cytoskeletal adaptor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
obscurin like cytoskeletal adaptor 1, transcript variant X7
transmembrane protein 198, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane protein 198, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
acid sensing ion channel subunit family member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GDP-mannose pyrophosphorylase A, transcript variant X2
GDP-mannose pyrophosphorylase A, transcript variant X4
GDP-mannose pyrophosphorylase A, transcript variant X1
GDP-mannose pyrophosphorylase A, transcript variant X3
GDP-mannose pyrophosphorylase A, transcript variant X5
mannose-1-phosphate guanyltransferase alpha isoform X2
mannose-1-phosphate guanyltransferase alpha isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 53% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SPEG neighbor protein
LOW QUALITY PROTEIN: striated muscle preferentially expressed protein kinase
uncharacterized LOC123278416, transcript variant X2
uncharacterized LOC123278416, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
aspartyl aminopeptidase, transcript variant X2
aspartyl aminopeptidase, transcript variant X8
aspartyl aminopeptidase, transcript variant X1
aspartyl aminopeptidase, transcript variant X3
aspartyl aminopeptidase, transcript variant X7
aspartyl aminopeptidase, transcript variant X6
aspartyl aminopeptidase, transcript variant X5
aspartyl aminopeptidase, transcript variant X4
protein tyrosine phosphatase receptor type N
receptor-type tyrosine-protein phosphatase-like N
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X2
dnaJ homolog subfamily B member 2 isoform X2
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
dnaJ homolog subfamily B member 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 359 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: tubulin alpha-1D chain-like
serine/threonine kinase 16, transcript variant X2
serine/threonine kinase 16, transcript variant X3
serine/threonine kinase 16, transcript variant X1
galactosidase beta 1 like, transcript variant X2
galactosidase beta 1 like, transcript variant X1
galactosidase beta 1 like, transcript variant X4
galactosidase beta 1 like, transcript variant X3
galactosidase beta 1 like, transcript variant X5
beta-galactosidase-1-like protein isoform X4
beta-galactosidase-1-like protein isoform X1
beta-galactosidase-1-like protein isoform X2
beta-galactosidase-1-like protein isoform X3
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X1
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X2
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X3
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X4
ankyrin repeat and zinc finger domain-containing protein 1 isoform X2
ankyrin repeat and zinc finger domain-containing protein 1 isoform X1
ankyrin repeat and zinc finger domain-containing protein 1 isoform X3
autophagy related 9A, transcript variant X1
autophagy related 9A, transcript variant X2
autophagy related 9A, transcript variant X3
autophagy related 9A, transcript variant X4
autophagy related 9A, transcript variant X5
autophagy related 9A, transcript variant X6
autophagy related 9A, transcript variant X7
autophagy related 9A, transcript variant X8
ATP binding cassette subfamily B member 6 (Langereis blood group)
ATP-binding cassette sub-family B member 6
zinc finger AN1-type containing 2B, transcript variant X3
zinc finger AN1-type containing 2B, transcript variant X2
zinc finger AN1-type containing 2B, transcript variant X1
AN1-type zinc finger protein 2B isoform X2
AN1-type zinc finger protein 2B isoform X1
AN1-type zinc finger protein 2B isoform X3
cyclin Pas1/PHO80 domain containing 1, transcript variant X1
cyclin Pas1/PHO80 domain containing 1, transcript variant X2
solute carrier family 23 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 23 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 23 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 23 member 3 isoform X1
solute carrier family 23 member 3 isoform X3
solute carrier family 23 member 3 isoform X2
non-homologous end joining factor 1, transcript variant X8
non-homologous end joining factor 1, transcript variant X2
non-homologous end joining factor 1, transcript variant X3
non-homologous end joining factor 1, transcript variant X7
non-homologous end joining factor 1, transcript variant X10
non-homologous end joining factor 1, transcript variant X11
non-homologous end joining factor 1, transcript variant X1
non-homologous end joining factor 1, transcript variant X6
non-homologous end joining factor 1, transcript variant X5
non-homologous end-joining factor 1 isoform X1
non-homologous end-joining factor 1 isoform X5
non-homologous end-joining factor 1 isoform X4
non-homologous end joining factor 1, transcript variant X4
non-homologous end joining factor 1, transcript variant X9
non-homologous end-joining factor 1 isoform X2
non-homologous end-joining factor 1 isoform X3
cilia and flagella associated protein 65
cilia- and flagella-associated protein 65
FEV transcription factor, ETS family member
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
cyclin dependent kinase 5 regulatory subunit 2
Wnt family member 6, transcript variant X3
Wnt family member 6, transcript variant X5
Wnt family member 6, transcript variant X2
Wnt family member 6, transcript variant X1
Wnt family member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein kinase AMP-activated non-catalytic subunit gamma 3
LOW QUALITY PROTEIN: 5'-AMP-activated protein kinase subunit gamma-3
sterol 26-hydroxylase, mitochondrial, transcript variant X1
sterol 26-hydroxylase, mitochondrial, transcript variant X2
tubulin tyrosine ligase like 4, transcript variant X3
tubulin tyrosine ligase like 4, transcript variant X4
tubulin tyrosine ligase like 4, transcript variant X5
tubulin tyrosine ligase like 4, transcript variant X2
tubulin tyrosine ligase like 4, transcript variant X1
tubulin polyglutamylase TTLL4 isoform X2
tubulin polyglutamylase TTLL4 isoform X3
tubulin polyglutamylase TTLL4 isoform X1
tubulin tyrosine ligase like 4, transcript variant X6
tubulin polyglutamylase TTLL4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine kinase 36, transcript variant X2
serine/threonine kinase 36, transcript variant X1
serine/threonine-protein kinase 36 isoform X2
serine/threonine-protein kinase 36 isoform X1
ring finger protein 25, transcript variant X1
ring finger protein 25, transcript variant X2
ring finger protein 25, transcript variant X3
E3 ubiquitin-protein ligase RNF25 isoform X1
E3 ubiquitin-protein ligase RNF25 isoform X2
E3 ubiquitin-protein ligase RNF25 isoform X3
mitochondrial chaperone BCS1, transcript variant X2
mitochondrial chaperone BCS1, transcript variant X1
zinc finger protein 142, transcript variant X1
zinc finger protein 142, transcript variant X2
zinc finger protein 142, transcript variant X3
ubiquitin specific peptidase 37, transcript variant X7
ubiquitin specific peptidase 37, transcript variant X8
ubiquitin specific peptidase 37, transcript variant X2
CCR4-NOT transcription complex subunit 9, transcript variant X1
CCR4-NOT transcription complex subunit 9 isoform X1
CCR4-NOT transcription complex subunit 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 9 isoform X3
CCR4-NOT transcription complex subunit 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 9 isoform X2
ubiquitin specific peptidase 37, transcript variant X5
ubiquitin specific peptidase 37, transcript variant X1
ubiquitin specific peptidase 37, transcript variant X4
ubiquitin specific peptidase 37, transcript variant X3
ubiquitin specific peptidase 37, transcript variant X9
ubiquitin specific peptidase 37, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 37 isoform X1
ubiquitin carboxyl-terminal hydrolase 37 isoform X2
ubiquitin carboxyl-terminal hydrolase 37 isoform X3
CTD small phosphatase 1, transcript variant X4
CTD small phosphatase 1, transcript variant X2
CTD small phosphatase 1, transcript variant X3
CTD small phosphatase 1, transcript variant X1
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X4
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X2
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X3
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X1
solute carrier family 11 member 1, transcript variant X2
solute carrier family 11 member 1, transcript variant X1
natural resistance-associated macrophage protein 1 isoform X1
natural resistance-associated macrophage protein 1 isoform X2
solute carrier family 11 member 1, transcript variant X3
ciliogenesis associated TTC17 interacting protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
LOW QUALITY PROTEIN: ciliogenesis-associated TTC17-interacting protein
transmembrane BAX inhibitor motif containing 1, transcript variant X2
transmembrane BAX inhibitor motif containing 1, transcript variant X1
angio associated migratory cell protein, transcript variant X1
angio associated migratory cell protein, transcript variant X2
angio-associated migratory cell protein isoform X1
angio-associated migratory cell protein isoform X2
G protein-coupled bile acid receptor 1, transcript variant X2
G protein-coupled bile acid receptor 1, transcript variant X4
G protein-coupled bile acid receptor 1, transcript variant X3
G protein-coupled bile acid receptor 1, transcript variant X1
G-protein coupled bile acid receptor 1 isoform X1
G-protein coupled bile acid receptor 1 isoform X2
actin related protein 2/3 complex subunit 2
actin-related protein 2/3 complex subunit 2
C-X-C chemokine receptor type 2-like, transcript variant X1
C-X-C chemokine receptor type 2-like, transcript variant X5
C-X-C chemokine receptor type 2-like, transcript variant X9
C-X-C chemokine receptor type 2-like, transcript variant X8
C-X-C chemokine receptor type 2-like, transcript variant X7
C-X-C chemokine receptor type 2-like, transcript variant X4
C-X-C chemokine receptor type 2-like, transcript variant X3
C-X-C chemokine receptor type 2-like, transcript variant X2
C-X-C chemokine receptor type 2-like, transcript variant X6
C-X-C chemokine receptor type 2-like isoform X1
C-X-C chemokine receptor type 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
RUN and FYVE domain containing 4, transcript variant X2
RUN and FYVE domain containing 4, transcript variant X1
RUN and FYVE domain containing 4, transcript variant X3
RUN and FYVE domain-containing protein 4 isoform X1
RUN and FYVE domain containing 4, transcript variant X4
RUN and FYVE domain-containing protein 4 isoform X2
uncharacterized LOC123278549, transcript variant X4
uncharacterized LOC123278549, transcript variant X3
uncharacterized LOC123278549, transcript variant X2
uncharacterized LOC123278549, transcript variant X1
uncharacterized LOC123278523, transcript variant X1
uncharacterized LOC123278523, transcript variant X3
uncharacterized LOC123278523, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
uncharacterized LOC123278521, transcript variant X3
uncharacterized LOC123278521, transcript variant X2
uncharacterized LOC123278521, transcript variant X1
uncharacterized LOC123278490, transcript variant X3
uncharacterized LOC123278490, transcript variant X2
uncharacterized LOC123278490, transcript variant X1
uncharacterized LOC123278490, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
insulin like growth factor binding protein 5
insulin-like growth factor-binding protein 5
insulin like growth factor binding protein 2
LOW QUALITY PROTEIN: insulin-like growth factor-binding protein 2
uncharacterized LOC123278534, transcript variant X9
uncharacterized LOC123278534, transcript variant X2
uncharacterized LOC123278534, transcript variant X10
uncharacterized LOC123278534, transcript variant X8
uncharacterized LOC123278534, transcript variant X11
uncharacterized LOC123278534, transcript variant X12
uncharacterized LOC123278534, transcript variant X7
uncharacterized LOC123278534, transcript variant X4
uncharacterized LOC123278534, transcript variant X6
uncharacterized LOC123278534, transcript variant X5
uncharacterized LOC123278534, transcript variant X1
uncharacterized LOC123278534, transcript variant X3
ribosomal protein L37a, transcript variant X2
ribosomal protein L37a, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X6
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 isoform X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
membrane associated ring-CH-type finger 4
X-ray repair cross complementing 5, transcript variant X2
X-ray repair cross complementing 5, transcript variant X1
X-ray repair cross-complementing protein 5 isoform X2
X-ray repair cross-complementing protein 5 isoform X1
transmembrane protein 169, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 169, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123278469, transcript variant X1
uncharacterized LOC123278469, transcript variant X4
uncharacterized LOC123278469, transcript variant X2
uncharacterized LOC123278469, transcript variant X3
uncharacterized LOC123278469, transcript variant X5
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
bifunctional purine biosynthesis protein ATIC
ATP binding cassette subfamily A member 12
von Willebrand factor C domain containing 2 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
von Willebrand factor C domain-containing protein 2-like
sperm associated antigen 16, transcript variant X1
sperm associated antigen 16, transcript variant X2
sperm associated antigen 16, transcript variant X3
sperm associated antigen 16, transcript variant X4
sperm-associated antigen 16 protein isoform X2
sperm-associated antigen 16 protein isoform X1
sperm-associated antigen 16 protein isoform X3
IKAROS family zinc finger 2, transcript variant X5
IKAROS family zinc finger 2, transcript variant X2
IKAROS family zinc finger 2, transcript variant X6
IKAROS family zinc finger 2, transcript variant X8
IKAROS family zinc finger 2, transcript variant X4
IKAROS family zinc finger 2, transcript variant X7
IKAROS family zinc finger 2, transcript variant X1
IKAROS family zinc finger 2, transcript variant X10
IKAROS family zinc finger 2, transcript variant X3
IKAROS family zinc finger 2, transcript variant X11
IKAROS family zinc finger 2, transcript variant X12
IKAROS family zinc finger 2, transcript variant X9
LOW QUALITY PROTEIN: receptor tyrosine-protein kinase erbB-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins